FRANCE – Ribonexus, a biotechnology start-up developing new therapies to overcome resistance to current targeted therapies in cancer patients, has received €2 million ($2.19 million) in funding from Bpifrance, the…
Read MoreRibonexus secures €2 million in deep tech financing from Bpifrance
